# Safety and Efficacy Study of NGGT002 in cPKU Adult Subjects

> **NCT06687733** · PHASE1,PHASE2 · RECRUITING · sponsor: **NGGT (Suzhou) Biotechnology Co., Ltd.** · enrollment: 18 (estimated)

## Conditions studied

- Phenylketonurias

## Interventions

- **GENETIC:** NGGT002

## Key facts

- **NCT ID:** NCT06687733
- **Lead sponsor:** NGGT (Suzhou) Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-25
- **Primary completion:** 2026-07-30
- **Final completion:** 2031-07-30
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06687733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06687733, "Safety and Efficacy Study of NGGT002 in cPKU Adult Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06687733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*